Programmable methylation engineering: Design principles from alkaloid biosynthesis

Methyltransferases (MTs) play a central role in alkaloid biosynthesis by catalyzing methylation reactions that critically shape scaffold diversification, bioactivity, solubility, and pharmacokinetic properties. However, their application in methyltransferase-tailored alkaloid biosynthesis (MTAB) remains constrained by limited catalytic plasticity, poor heterologous expression, structural instability, and imbalanced cofactor homeostasis within the S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) cycle. In this review, we provide a design-oriented synthesis of recent advances in MTAB, organized into three hierarchical levels: enzyme-level engineering, cofactor-level optimization, and system-level metabolic control. Specifically, we highlight key design principles for programmable methylation, including (i) expanding catalytic plasticity through natural diversity mining and structure-guided engineering, (ii) enhancing MT activity and robustness via expression optimization, structural stabilization, and host adaptation, (iii) sustaining high methylation flux through integrated engineering of SAM/SAH cycle, including SAM supply, and SAH degradation, and (iv) maintaining pathway performance by balancing metabolic flux and mitigating cytotoxicity through dynamic regulation, compartmentalization, and transporter engineering. Together, these principles establish programmable methylation as a unifying framework for the rational design of MT-driven pathways, enabling robust and scalable biosynthesis of complex alkaloids and other methylated high-value chemicals.